Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 14, 2017; 23(10): 1851-1856
Published online Mar 14, 2017. doi: 10.3748/wjg.v23.i10.1851
Published online Mar 14, 2017. doi: 10.3748/wjg.v23.i10.1851
Table 2 Biochemical parameters before and after the procedure
| Parameters | Pre-ablation | Post-ablation (day 3) | Normal |
| Bilirubin (μmol/L) | 128 ± 65 | 63 ± 29 | 0-21 |
| ALP (IU/L) | 1240 ± 865 | 1032 ± 790 | 30-130 |
| ALT (IU/L) | 105 ± 58 | 79 ± 40 | < 40 |
| GGT (IU/L) | 747 ± 729 | 720 ± 625 | < 55 |
| LDH (IU/L) | 60 ± 84 | 311 ± 45 | 0-250 |
| AST (IU/L) | 98 ± 49 | 65 ± 34 | < 40 |
| CRP (mg/L) | 15 ± 8 | 12 ± 7 | 0-5 |
| Amylase (IU/L) | 80 ± 15 | 79 ± 12 | 0-90 |
- Citation: Xia N, Gong J, Lu J, Chen ZJ, Zhang LY, Wang ZM. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result. World J Gastroenterol 2017; 23(10): 1851-1856
- URL: https://www.wjgnet.com/1007-9327/full/v23/i10/1851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i10.1851